Surely the Scoping Study is a pathway to success and it's a very smart and achievable one.
https://www.investi.com.au/api/announcements/rxl/db1bc3e6-24c.pdf
Leadership officially changed to Rob Ryan 5 days later.
The SS is Ryan's not AP's or Mair's or the geos although they would have had input.
It is what he did at Bardoc and well outside AP's geo/banker skill set.
Ryan went on to present very insightful presentations on how his pathway to production is viable.
Below is one of them
Ryan has earned performance rights and I will be voting for him to get them.
- Forums
- ASX - By Stock
- RXL
- Rox in 2023
RXL
rox resources limited
Add to My Watchlist
3.64%
!
28.5¢

Rox in 2023, page-62
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.5¢ |
Change
0.010(3.64%) |
Mkt cap ! $208.8M |
Open | High | Low | Value | Volume |
27.5¢ | 29.5¢ | 27.3¢ | $574.8K | 2.045M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 77185 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 352154 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 77185 | 0.275 |
15 | 390742 | 0.270 |
3 | 243500 | 0.265 |
5 | 378000 | 0.260 |
2 | 243000 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 352154 | 1 |
0.295 | 120000 | 2 |
0.300 | 328300 | 5 |
0.305 | 146184 | 3 |
0.310 | 149230 | 4 |
Last trade - 15.59pm 26/06/2025 (20 minute delay) ? |
Featured News
RXL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online